Spectrum Pharmaceuticals (NasdaqGS: SPPI) , a biotechnology
company with fully integrated commercial and drug development operations
with a primary focus in hematology and oncology, today announced that
the United States Patent and Trademark Office (USPTO) has issued U.S.
for Spectrum Pharmaceuticals Announces Issue of a New Patent for Beleodaq™ (belinostat) for Injection with Patent Term Adjustment till 2027 investment picks